首页> 美国卫生研究院文献>PLoS Clinical Trials >The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
【2h】

The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice

机译:非那雄胺和度他雄胺对裸鼠体内WPE1-NA22前列腺癌异种移植物生长的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background5α-reductase 1 (5αR1) and 5α-reductase 2 (5αR2) convert testosterone into the more potent androgen dihydrotestosterone. 5αR2 is the main isoenzyme in normal prostate tissue; however, most prostate tumors have increased 5αR1 and decreased 5αR2 expression. Previously, finasteride (5αR2 inhibitor) treatment begun 3 weeks post-tumor implantation had no effect on Dunning R3327-H rat prostate tumor growth. We believe the tumor compensated for finasteride treatment by increasing tumor 5αR1 expression or activity. We hypothesize that finasteride treatment would not significantly alter tumor growth even if begun before tumor implantation, whereas dutasteride (5αR1 and 5αR2 inhibitor) treatment would decrease tumor growth regardless of whether treatment was initiated before or after tumor implantation.
机译:Background5α-还原酶1(5αR1)和5α-还原酶2(5αR2)将睾丸激素转化为更有效的雄激素二氢睾丸激素。 5αR2是正常前列腺组织中的主要同工酶。但是,大多数前列腺肿瘤的5αR1表达增加而5αR2表达降低。以前,在肿瘤植入后3周开始进行非那雄胺(5αR2抑制剂)治疗对Dunning R3327-H大鼠前列腺肿瘤的生长没有影响。我们相信该肿瘤通过增加肿瘤5αR1的表达或活性来补偿非那雄胺治疗。我们假设即使在肿瘤植入之前开始使用非那雄胺治疗也不会显着改变肿瘤的生长,而无论是否在肿瘤植入之前或之后开始治疗,度他雄胺(5αR1和5αR2抑制剂)治疗都会降低肿瘤的生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号